Acro Biomedical (ACBM) Shareholder's Equity Growth (1y) (2016 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | EQV Ventures Acquisition | 477.69 Mn | 477.69 Mn | - |
| 2 | Berto Acquisition | 316.66 Mn | 316.66 Mn | - |
| 3 | Centurion Acquisition | 311.94 Mn | 311.94 Mn | - |
| 4 | Churchill Capital Corp IX | 311.36 Mn | 311.36 Mn | - |
| 5 | Agriculture & Natural Solutions Acquisition | 301.94 Mn | 301.94 Mn | - |
| 6 | Siddhi Acquisition Corp (Cayman Islands) | 286.76 Mn | 286.76 Mn | - |
| 7 | Bold Eagle Acquisition | 276.06 Mn | 276.06 Mn | - |
| 8 | Cartesian Growth Corp III | 270.68 Mn | 270.68 Mn | - |
| 9 | Oyster Enterprises II Acquisition | 266.84 Mn | 266.84 Mn | - |
| 10 | Acro Biomedical | - | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -31.19% |
| Sep 30, 2025 | -51.53% |
| Jun 30, 2025 | -14.88% |
| Mar 31, 2025 | -13.69% |
| Dec 31, 2024 | -14.77% |
| Sep 30, 2024 | -19.15% |
| Jun 30, 2024 | -181.38% |
| Mar 31, 2024 | -165.05% |
| Dec 31, 2023 | -152.84% |
| Sep 30, 2023 | -148.69% |
| Jun 30, 2023 | -40.92% |
| Mar 31, 2023 | -36.12% |
| Dec 31, 2022 | -24.44% |
| Sep 30, 2022 | -13.38% |
| Jun 30, 2022 | -10.20% |
| Mar 31, 2022 | 2.28% |
| Dec 31, 2021 | -6.15% |
| Sep 30, 2021 | -23.78% |
| Jun 30, 2021 | -21.64% |
| Mar 31, 2021 | -28.52% |
| Dec 30, 2020 | -14.08% |
| Sep 30, 2020 | -14.67% |
| Jun 30, 2020 | -13.82% |
| Mar 31, 2020 | -11.86% |
| Dec 31, 2019 | -31.65% |
| Sep 30, 2019 | -29.66% |
| Jun 30, 2019 | 21.96% |
| Mar 31, 2019 | 51.01% |
| Dec 31, 2018 | 97.42% |
| Sep 30, 2018 | 142.93% |
| Jun 30, 2018 | 2,859.97% |
| Mar 31, 2018 | 4,161.01% |
| Dec 31, 2017 | 2,763.96% |
| Sep 30, 2017 | 3,556.57% |
| Jun 30, 2017 | -224.99% |
| Mar 31, 2017 | -292.42% |
| Sep 30, 2016 | -151.66% |